Dysfunction of regulatory volume increase is a key component of apoptosis

FEBS Lett. 2006 Nov 27;580(27):6513-7. doi: 10.1016/j.febslet.2006.10.074. Epub 2006 Nov 9.

Abstract

Sustained cell shrinkage is a major hallmark of apoptotic cell death. In apoptotic cells, whole cell volume reduction, called apoptotic volume decrease (AVD), proceeds until fragmentation of cells. Under non-apoptotic conditions, human epithelial HeLa cells exhibited a slow regulatory volume increase (RVI) after osmotic shrinkage induced by exposure to hypertonic solution. When AVD was induced by treatment with a Fas ligand, TNF-alpha or staurosporine, however, it was found that HeLa cells failed to undergo RVI. When RVI was inhibited by combined application of Na+/H+ exchanger (NHE) and anion exchanger blockers, hypertonic stress induced prolonged shrinkage followed by caspase-3 activation in HeLa cells. Hypertonicity also induced apoptosis in NHE1-deficient PS120 fibroblasts, which lack the RVI response. When RVI was restored by transfection of these cells with NHE1, hypertonicity-induced apoptosis was completely prevented. Thus, it is concluded that RVI dysfunction is indispensable for the persistence of AVD and induction of apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis* / drug effects
  • Apoptosis* / genetics
  • Caspase 3 / metabolism
  • Cation Transport Proteins / deficiency
  • Cation Transport Proteins / metabolism
  • Cell Size*
  • DNA Fragmentation* / drug effects
  • Enzyme Inhibitors / pharmacology
  • Fas Ligand Protein / metabolism
  • Fas Ligand Protein / pharmacology
  • Fibroblasts / cytology
  • Fibroblasts / metabolism*
  • HeLa Cells
  • Humans
  • Osmosis / drug effects
  • Osmotic Pressure / drug effects
  • Sodium-Hydrogen Exchanger 1
  • Sodium-Hydrogen Exchangers / antagonists & inhibitors
  • Sodium-Hydrogen Exchangers / metabolism
  • Staurosporine / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Cation Transport Proteins
  • Enzyme Inhibitors
  • Fas Ligand Protein
  • SLC9A1 protein, human
  • Sodium-Hydrogen Exchanger 1
  • Sodium-Hydrogen Exchangers
  • Tumor Necrosis Factor-alpha
  • Caspase 3
  • Staurosporine